免疫治疗背景下提高临床肿瘤教学水平的探讨

发布时间：2018-10-22 12:56

【摘要】：肿瘤发病率的日益攀升以及临床肿瘤学的迅速发展,对培养专业的临床肿瘤学人才提出了更高的要求。随着第一个细胞免疫治疗药物Sipuleucel-T被美国FDA批准用于晚期前列腺癌的治疗,肿瘤治疗进入免疫治疗的新时代,现有传统临床肿瘤学教学方法及观念已经不能适应目前的要求,因此必须提高临床教学水平。本文在肿瘤免疫治疗迅速发展背景下,对如何提高临床肿瘤教学水平进行思考与探讨,通过加强肿瘤分子生物学及细胞分子免疫学理论教学,以及在教学过程中贯穿循证医学与个体化治疗相结合的理念、引入多学科参与的肿瘤综合治疗模式,并强调心理干预和人文关怀的重要性,兼顾教学理论和临床实践最新进展及趋势,有效地帮助学生树立全面、科学的临床肿瘤治疗理念,掌握改善临床肿瘤治疗的有效方法,切实提升临床肿瘤学的教学质量和水平,培养出能胜任现代临床肿瘤学实践需求的专业人才。
[Abstract]:With the increasing incidence of cancer and the rapid development of clinical oncology, higher requirements have been put forward for the cultivation of clinical oncology professionals. With the first cellular immunotherapy drug Sipuleucel-T approved by FDA in the United States for the treatment of advanced prostate cancer, tumor therapy has entered a new era of immunotherapy, and the existing traditional teaching methods and concepts of clinical oncology can no longer meet the current requirements. Therefore, the clinical teaching level must be improved. In this paper, under the background of rapid development of tumor immunotherapy, how to improve the teaching level of clinical tumor was discussed, and the teaching of tumor molecular biology and cell-molecular immunology was strengthened. In addition, the concept of combining evidence-based medicine with individualized therapy was introduced into the teaching process, and the importance of psychological intervention and humanistic care was emphasized. Taking into account the latest progress and trend of teaching theory and clinical practice, it can effectively help students to set up comprehensive and scientific clinical tumor treatment concept, master effective methods to improve clinical tumor treatment, and improve the teaching quality and level of clinical oncology. Cultivate professional talents who can meet the needs of modern clinical oncology practice.
【作者单位】：首都医科大学附属北京世纪坛医院肿瘤内科
【基金】：国家自然科学基金面上项目(81172534) 北京市科委科技创新基地培育与发展工程项目(Z131102002813059)
【分类号】：R-4;G642

【参考文献】